Status:
COMPLETED
Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes
Lead Sponsor:
Pfizer
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
B1621007 is designed to study the safety and efficacy of PF-04937319 in patients with type 2 diabetes
Eligibility Criteria
Inclusion
- patients with type 2 diabetes, on metformin, age between 18-55 yrs, male or female
Exclusion
- patients with type 1 diabetes, medically unstable, unacceptable clinical laboratory test results at screening
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
345 Patients enrolled
Trial Details
Trial ID
NCT01475461
Start Date
November 1 2011
End Date
January 1 2013
Last Update
January 31 2017
Active Locations (63)
Enter a location and click search to find clinical trials sorted by distance.
1
Anaheim Clinical Trials
Anaheim, California, United States, 92801
2
National Research Institute
Los Angeles, California, United States, 90057
3
Encompass Clinical Research
Spring Valley, California, United States, 91978
4
The Family Doctors of Belleview
Belleview, Florida, United States, 34420